Cancer drugs proving worth earlier in testingMichael Weitz was out of options. The Californian had endured chemotherapy, radiation and surgery but his lung cancer still spread to his bones and brain. With time running out, the emergency room physician entered a Phase I study More… |
US new drug approvals hit 16-year highUS regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to generic drug makers because of patent expirations. More… |
How drug cartels used HSBC to channel fundsIn February 2008, Mexican authorities told the CEO of HSBC Holdings' Mexico unit that a local drug lord referred to the bank as the "place to launder money," US prosecutors said on Tuesday, as they announced a rec More… |
Ginkgo herb can't prevent Alzheimer'sA Chinese herb called Ginkgo biloba billed by some as a potential over-the-counter wonder drug that boosts mental dexterity and sharpens the memory has been found to do nothing to prevent the onset of Alzheimer's disease. More… |
Roche's top drug rejected for breast cancerRoche Holding's cancer drug Avastin has been rejected by Britain's healthcare cost agency as a first-line treatment for advanced breast cancer, the latest in a series of setbacks for this medicine. The National Institute for Health and Cli More… |
Diabetes drug may help fight cancerA cheap and relatively safe diabetes drug, metformin, might have cancer-fighting properties, according to an international study - but findings fall short of proving it actually can stave off cancer. Researchers, whose findings were publis More… |
Sanofi says MS treatment reduced relapse rateSanofi said on Friday a trial of its multiple-sclerosis treatment teriflunomide found that a daily dose of the drug reduced the rate of relapse by 36 per cent compared with a placebo. Teriflunomide, marketed as Aubagio, is one of the two m More… |
Pfizer drug effective in rare children's cancersA Pfizer lung cancer drug appears to be a highly effective treatment for children with a rare but aggressive type of lymphoma and other cancers, according to data from an early stage study released on Wednesday. More… |
Roche stops drug trial as data disappointsSwiss drugmaker Roche has ended efforts to develop a heart disease drug that according to some industry analysts could have achieved $10 billion annual sales, after poor results from a late stage trial. The D More… |
$272m worth drug haul by Dubai CustomsDubai Customs has foiled an attempt to smuggle 91 million Tramadol tablets, with a total value of about Dh1billion ($272 million). The drug is prohibited to be used outside its normal medical use, said a statement.The More… |








